Recent Updates — APDN
BNB Plus Corp. announced a strategic transition from a digital asset treasury company focused on the BNB Chain ecosystem to an operating company building institutional technology infrastructure for blockchain and agentic AI applications. The company intends to redirect resources toward assembling network deployment layers that enable financial institutions to adopt open network technologies with necessary security, compliance, and risk management assurances. Additionally, BNB Plus is evaluating options to strengthen the strategic positioning of its subsidiary LineaRx, Inc., which operates an enzymatic DNA manufacturing platform for genetic medicines, with the objective of realizing value for stockholders. The company remains an active participant in the BNB Chain ecosystem while expanding its relationship with GlobalStake Infrastructure LLC. BNB Plus Corp. operates in the technology and biotechnology sectors, providing blockchain infrastructure services and nucleic acid production solutions.
BNB Plus Corp. reported the resignation of directors Robert B. Catell, Joseph D. Ceccoli, and Dr. Yacov Shamash effective September 3, 2026, citing no disagreements with company operations. The Board appointed Richard Shorten, Todd Larsen, and Lok Lee as new directors to fill these vacancies. Mr. Shorten brings expertise in blockchain and AI infrastructure through his role at GlobalStake Infrastructure, LLC. Concurrently, the Company engaged GlobalStake for a strategic review of its business and capital structure, paying a $300,000 pre-paid advisory fee over an initial four-month term led by Mr. Shorten. This engagement follows previous financial transactions with Comstock MultiChain Fund, LP, which holds significant stakes in GlobalStake and has participated in the Company's prior private placements. BNB Plus Corp. operates in the digital assets and cryptocurrency sector.
BNB Plus Corp. mutually terminated its Strategic Digital Assets Services Agreement and Strategic Advisor Agreement with Cypress LLC entities effective July 23, 2026. The settlement requires the company to pay $1,000,000 in cash ($500,000 upfront plus twelve monthly installments) and issue 200,000 shares of Series B-1 Convertible Preferred Stock. Joshua Kruger resigned as Chairman and director effective July 31, 2026, while Chief Investment Officer Patrick Horsman ceased his role immediately. The agreement includes a standstill provision preventing the Cypress Parties from acquiring additional equity or soliciting proxies until September 29, 2030, alongside the rescission of nearly 700,000 warrants and modification of remaining warrants. BNB Plus Corp. operates in the crypto technology sector, providing digital asset management services.
BNB Plus Corp. received a delisting notice from Nasdaq, resulting in the suspension of trading of its common stock on the Nasdaq Capital Market effective July 14, 2026. The delisting follows the company's failure to satisfy the $1.00 minimum bid price requirement. Although the company requested a hearing and an extension, the Nasdaq Hearings Panel declined the extension. The company intends to request a review by the Nasdaq Listing and Hearing Review Council. BNB Plus Corp. expects its common stock to begin trading on the OTCQB Venture Market under the symbol BNBX on July 14, 2026. The company operates in the health sciences sector.
BNB Plus Corp. closed a Securities Purchase Agreement on May 28, 2026, issuing 2,380,953 shares of Series B-1 Preferred Stock and Common Warrants for $2.5 million in gross proceeds. The company also entered into an Inducement Agreement on May 31, 2026, for approximately $0.22 million in warrant exercises, bringing total anticipated proceeds from all Inducement Agreements to approximately $1.72 million.